Anti-Inflammatory Therapies for Severe Community-Acquired Pneumonia
- 19/04/2024
Emerging evidence highlights the potential advantages of employing anti-inflammatory therapies like macrolide antibiotics and corticosteroids in managing severe community-acquired pneumonia (CAP). Although their use remains a subject of debate, recent findings indicate improved clinical outcomes, and support the adoption of a tailored approach that emphasises personalised medicine strategies...
READ MORE